We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.06B
AUM Growth
-$27.8M
Cap. Flow
-$125M
Cap. Flow %
-4.06%
Top 10 Hldgs %
10.6%
Holding
459
New
33
Increased
132
Reduced
231
Closed
52

Sector Composition

Rank Sector Weight
1 Financials 18.56%
2 Technology 14.47%
3 Industrials 13.56%
4 Consumer Discretionary 10.49%
5 Healthcare 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
351
Alcoa
AA
$13.2B
$1.47M 0.05%
62,788
-5,060
-7% -$126K
EW icon
352
Edwards Lifesciences
EW
$51.7B
$1.41M 0.05%
22,947
-669
-3% -$40.5K
BG icon
353
Bunge Global
BG
$20.8B
$1.39M 0.05%
24,995
-1,785
-7% -$95.2K
AMD icon
354
Advanced Micro Devices
AMD
$789B
$1.39M 0.05%
45,782
+23,495
+105% +$670K
AMAT icon
355
Applied Materials
AMAT
$428B
$1.38M 0.05%
30,728
-2,905
-9% -$122K
BEAT
356
DELISTED
BioTelemetry, Inc.
BEAT
$1.35M 0.04%
27,992
+10,876
+64% +$572K
ENS icon
357
EnerSys
ENS
$6.99B
$1.33M 0.04%
19,489
-21,857
-53% -$1.43M
SRPT icon
358
Sarepta Therapeutics
SRPT
$1.77B
$1.3M 0.04%
8,590
-1,369
-14% -$166K
DXC icon
359
DXC Technology
DXC
$1.73B
$1.3M 0.04%
23,515
-1,460
-6% -$84.5K
RNG icon
360
RingCentral
RNG
$5.28B
$1.29M 0.04%
11,199
-57,044
-84% -$6.58M
LAB icon
361
Standard BioTools
LAB
$314M
$1.22M 0.04%
+98,631
New +$1.26M
WGO icon
362
Winnebago Industries
WGO
$909M
$1.21M 0.04%
31,291
-2,810
-8% -$98.9K
UBER icon
363
Uber
UBER
$153B
$1.18M 0.04%
+25,378
New +$1.08M
SCSC icon
364
Scansource
SCSC
$1.12B
$1.17M 0.04%
36,060
-2,335
-6% -$79.4K
EWBC icon
365
East-West Bancorp
EWBC
$18B
$1.16M 0.04%
24,696
-4,020
-14% -$193K
EPAM icon
366
EPAM Systems
EPAM
$5.03B
$1.14M 0.04%
6,606
-840
-11% -$145K
ODT
367
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1.12M 0.04%
30,543
+1,782
+6% +$42.7K
HOFT icon
368
Hooker Furnishings Corp
HOFT
$166M
$1.1M 0.04%
53,414
-4,424
-8% -$119K
EOLS icon
369
Evolus
EOLS
$501M
$1.08M 0.04%
+74,085
New +$1.47M
HUBS icon
370
HubSpot
HUBS
$10.5B
$1.08M 0.04%
+6,318
New +$1.1M
AMC icon
371
AMC Entertainment Holdings
AMC
$2.31B
$1.05M 0.03%
11,311
-682
-6% -$90.9K
BATRK icon
372
Atlanta Braves Holdings Series B
BATRK
$3.21B
$1.02M 0.03%
36,502
+13,240
+57% +$363K
LFCR icon
373
Lifecore Biomedical
LFCR
$190M
$1M 0.03%
107,150
-8,590
-7% -$86.7K
LOVE
374
LoveSac
LOVE
$261M
$996K 0.03%
32,055
+14,818
+86% +$509K
MYGN icon
375
Myriad Genetics
MYGN
$312M
$996K 0.03%
35,866
-3,530
-9% -$99.7K

Similar funds

Chartwell Investment Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Chartwell Investment Partners held 459 positions worth $3.06B, down 0.9% from $3.09B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Chartwell Investment Partners withdrew a net $125M in Q2 2019, closing 52 positions and reducing 231 holdings. Its most notable exit was Integrated Device Technology I, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in Universal Health Services worth $12.8M.

  • Chartwell Investment Partners's largest Q2 2019 buy was Universal Health Services: 98,140 shares worth $12.8M.
  • Chartwell Investment Partners added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $7.77M increase.
  • Chartwell Investment Partners's biggest Q2 2019 reduction was LHC Group LLC, cutting an estimated $22.5M.
  • Chartwell Investment Partners fully exited Integrated Device Technology I in Q2 2019, selling an estimated $19.3M.
  • Chartwell Investment Partners's ten largest holdings make up 11% of its $3.06B portfolio in Q2 2019.
  • Chartwell Investment Partners opened 33 new positions and closed 52 in Q2 2019.
  • Chartwell Investment Partners's portfolio value fell 0.9% quarter-over-quarter to $3.06B.

Based on Chartwell Investment Partners's 13F filing for Q2 2019, filed 19 Aug 2019.